Concepedia

Jubo Wang

JW

Statistics

Publications

30

Citations

1.3K

H-Index

18

Active since

2011

Affiliations

China Pharmaceutical University(Current)

State Key Laboratory of Natural Medicine

Shanghai Institute of Materia Medica

Chinese Academy of Sciences

Second Affiliated Hospital of Xi'an Jiaotong University

Jubo Wang is an author at China Pharmaceutical University specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

2011–2024

30

Publications

30

CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma

Jingyue Yao, Jubo Wang, Ye Xu et al. · Autophagy · 2021 · 258 citations · Full text

, , +14

Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity

Jinlei Bian, Jie Ren, Yongren Li et al. · Bioorganic Chemistry · 2018 · 131 citations

, , +6

Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions

Xi Xu, Ying Meng, Lei Li et al. · Journal of Medicinal Chemistry · 2018 · 112 citations · Full text

, , +11

Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion

Xiaqiu Qiu, Yuan‐Qing Li, Bin Yu et al. · European Journal of Medicinal Chemistry · 2020 · 88 citations · Full text

, , +13

Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site

Xi Xu, Jubo Wang, Min Wang et al. · Journal of Medicinal Chemistry · 2021 · 64 citations · Full text

, , +15

1–5 of 30